Lymphomas -oreb (2)

Nankunda Oreb

The material outlines the WHO 2001 classification of B‑cell, T‑cell, and NK‑cell neoplasms, distinguishing indolent, aggressive, and very aggressive disease behavior. Epidemiologic patterns, typical systemic and local manifestations, and the spectrum of clinical presentations are described. Diagnostic strategies include bone‑marrow biopsy, imaging modalities, and lymph node histology. Staging follows the Ann Arbor system with A/B/E subcategories. Treatment recommendations emphasize chemo‑immunotherapy (e.g., rituximab‑CHOP) for indolent disease and highlight stem‑cell transplantation for select aggressive subtypes.